Status:
UNKNOWN
Intravitreal Bevasizumab Versus Intravitreal Triamcinolone in Central Retinal Vein Occlusion (CRVO)
Lead Sponsor:
Shahid Beheshti University of Medical Sciences
Collaborating Sponsors:
Ophthalmic Research Center
Conditions:
Central Retinal Vein Occlusion
Eligibility:
All Genders
Phase:
PHASE2
Brief Summary
This randomized clinical trial is conducted to evaluate the effect of three intravitreal injections of bevasizumab versus two intravitreal injections of triamcinolone in acute central retinal vein occ...
Eligibility Criteria
Inclusion
- Recent onset (less than 3 months) central retinal vein occlusion
Exclusion
- Any previous intervention
Key Trial Info
Start Date :
January 1 2010
Trial Type :
INTERVENTIONAL
End Date :
December 1 2010
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01178697
Start Date
January 1 2010
End Date
December 1 2010
Last Update
August 10 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Imam Hossein medical center
Tehran, Tehran Province, Iran, 166666